Medico Remedies Limited has informed the Exchange regarding Appointment of Mr Maheshkumar Darji as Executive Director of the company w.e.f. July 30, 2025.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medico Remedies' board, at its meeting on July 30, 2025, approved several key changes. Mr. Harshit Mehta was re-appointed as Managing Director for another three years starting September 17, 2025, subject to shareholder approval. Mr. Haresh Mehta will continue as Chairman & Whole-Time Director despite turning 70 on August 17, 2025, also pending shareholder approval. Mr. Maheshkumar Darji, currently General Manager – Plant at the Palghar facility with over 20 years of pharma experience, was appointed as Additional Executive Director. Separately, Secretarial Auditor Mr. Haresh Sanghvi resigned due to medical grounds, and Ms. Shreya Shah (Practicing Company Secretary with 10+ years' experience) was appointed in his place for a five-year term covering FY 2025-26 to FY 2029-30. The board also issued the notice for the 31st Annual General Meeting.
These are largely routine governance continuities — the Mehta family retains control of key leadership, with an internal operations professional elevated to the board. The Secretarial Auditor change is due to health reasons and a successor is already in place, so no material governance red flag. Shareholders will need to approve the MD re-appointment, Chairman continuation, Darji's directorship, and the new auditor at the upcoming AGM.